News

Regulatory affairsRegulatory Round-up - January 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Regulatory Round-up - October 2023Regulatory Round-up - October 2023Challenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesCryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene TherapiesRegulatory Round-up - September 2023Regulatory Round-up - September 2023Risky Business: How to de-risk your ATMP asset to attract investmentRisky Business: How to de-risk your ATMP asset to attract investmentCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandCell and Gene Therapy Catapult launches new network for the advanced therapies industry in ScotlandRegulatory Round-up - August 2023Regulatory Round-up - August 2023Cell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult, Rentschler Biopharma and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapiesCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformCell and Gene Therapy Catapult to support FourPlus in testing its immersive technology training platformPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesRegulatory Round-up - July 2023Regulatory Round-up - July 2023Cell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business OfficerCell and Gene Therapy Catapult appoints Jeanette Evans as Chief Business Officer